Sanj K. Patel, CHAIRMAN & CEO at Kiniksa Pharmaceuticals, Ltd. (KNSA), sold 130,024 shares at $21.02 ($2.7M) on 2024-03-07, disclosed to the SEC on 2024-03-11.
Scheduled sale ($2.7M) by CHAIRMAN & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.02 | 65,012 | $1.4M | 50.0% |
| 2 | $21.02 | 65,012 | $1.4M | 50.0% |
| Total | $21.02 avg | 130,024 | $2.7M | 100% |
| Filing → |
| KNSA | SELL | 2026-04-08 | $364K | — | Filing → |
| KNSA | SELL | 2025-10-22 | $20.0M | — | Filing → |
| KNSA | SELL | 2025-05-28 | $4.6M | — | Filing → |